Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Research Brief: Targeting Genes to Specific Neurons
14 October 2010. Gene therapy is an important research strategy and carries hope of becoming a viable treatment in neurodegenerative disease. Lentiviruses are widely used to deliver genes to mammalian cells in vivo, but unfortunately, these viral particles infect a wide variety of cell types, requiring careful selection of gene elements to restrict expression to cells of interest. A different approach is described in the October 10 Nature Methods. Researchers led by Christian Buchholz at the Paul Ehrlich Institute, Langen, Germany, modified the outer coat of lentiviruses to display single-chain antibodies that are specific to certain cell surface proteins. As shown below, viral particles studded with antibodies to GluA2/4 AMPA receptor subunits specifically deliver their cargo (in this case, the gene for green fluorescent protein) to glutamatergic neurons in the hippocampus and no other cells.

Lentiviral vectors displaying single-chain antibodies to the GluA2/4 subunits of AMPA receptors specifically transfect glutamatergic neurons with the green fluorescent protein gene (right) when injected into the stratum radiatum (SR) of the mouse brain. Unlike normal lentiviruses (left), the GluA2/4 viruses targeted mostly cells in the dentate gyrus (DG) and CA1 through CA3 fields of the hippocampus. The glia-rich corpus callosum (CC) and lacunosum-moleculare (LM) border showed little transfection. (Reprinted by permission from Macmillan Publishers Ltd: Nature Methods, advance online publication, 10 October 2010 [doi: 10.1038/nmeth.1514])

The targeting method has “unprecedented specificity,” according to the authors, and also works for other cell types, including immune and vascular cells. It could improve gene targeting in experimental settings and may add a level of safety to gene therapies by reducing risks associated with “off-target” gene expression.—Tom Fagan.

Reference:
Anliker B, Abel T, Kneissl S, Hlavaty J, Caputi A, Brynza J, Schneider IC, Munch RC, Petznek H, Kontermann RE, Koehl U, Johnston ICD, Keinanen K, Muller UC, Hohenadl C, Monyer H, Cichutek K, Buchholz CJ. Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors. Nature Methods. 2010 October 10. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad